BACKGROUND: Published data support the presence of etiologic heterogeneity by breast tumor subtype, but few studies have assessed this in Hispanic populations. METHODS: We assessed tumor subtype prevalence and associations between reproductive factors and tumor subtypes in 1,041 women of Mexican descent enrolled in a case-only, binational breast cancer study. Multinomial logistic regression comparing HER2(+) tumors and triple-negative breast cancer (TNBC) to luminal A tumors was conducted. RESULTS: Compared with women with luminal A tumors, those with a later age at first pregnancy were less likely to have TNBC [OR, 0.61; 95% confidence interval (CI), 0.39-0.95], whereas those with three or more full-term pregnancies were more likely to have TNBC (OR, 1.68; 95% CI, 1.10-2.55). A lower odds of TNBC was shown for longer menstruation duration, whether before first pregnancy (OR, 0.78; 95% CI, 0.65-0.93 per 10 years) or menopause (OR, 0.79; 95% CI, 0.69-0.91 per 10 years). Patients who reported breastfeeding for more than 12 months were over twice as likely to have TNBC than luminal A tumors (OR, 2.14; 95% CI, 1.24-3.68). Associations comparing HER2(+) with luminal A tumors were weak or nonexistent except for the interval between last full-term pregnancy and breast cancer diagnosis. CONCLUSIONS: Findings show etiologic heterogeneity by tumor subtype in a population of Hispanic women with unique reproductive profiles. IMPACT: Identification of etiologically distinct breast tumor subtypes can further improve our understanding of the disease and help provide personalized prevention and treatment regimens.
BACKGROUND: Published data support the presence of etiologic heterogeneity by breast tumor subtype, but few studies have assessed this in Hispanic populations. METHODS: We assessed tumor subtype prevalence and associations between reproductive factors and tumor subtypes in 1,041 women of Mexican descent enrolled in a case-only, binational breast cancer study. Multinomial logistic regression comparing HER2(+) tumors and triple-negative breast cancer (TNBC) to luminal A tumors was conducted. RESULTS: Compared with women with luminal A tumors, those with a later age at first pregnancy were less likely to have TNBC [OR, 0.61; 95% confidence interval (CI), 0.39-0.95], whereas those with three or more full-term pregnancies were more likely to have TNBC (OR, 1.68; 95% CI, 1.10-2.55). A lower odds of TNBC was shown for longer menstruation duration, whether before first pregnancy (OR, 0.78; 95% CI, 0.65-0.93 per 10 years) or menopause (OR, 0.79; 95% CI, 0.69-0.91 per 10 years). Patients who reported breastfeeding for more than 12 months were over twice as likely to have TNBC than luminal A tumors (OR, 2.14; 95% CI, 1.24-3.68). Associations comparing HER2(+) with luminal A tumors were weak or nonexistent except for the interval between last full-term pregnancy and breast cancer diagnosis. CONCLUSIONS: Findings show etiologic heterogeneity by tumor subtype in a population of Hispanic women with unique reproductive profiles. IMPACT: Identification of etiologically distinct breast tumor subtypes can further improve our understanding of the disease and help provide personalized prevention and treatment regimens.
Authors: Mariana Chavez-MacGregor; Sjoerd G Elias; N Charlotte Onland-Moret; Yvonne T van der Schouw; Carla H Van Gils; Evelyn Monninkhof; Diederick E Grobbee; Petra H M Peeters Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-04 Impact factor: 4.254
Authors: Priscilla Ming Yi Lee; Chi Hei Kwok; Wing Cheong Chan; Cherry Wu; Koon-Ho Tsang; Sze-Hong Law; Yiu-Cheong Yeung; Feng Wang; Xiaohong R Yang; Lap Ah Tse Journal: Horm Cancer Date: 2020-06-03 Impact factor: 3.869
Authors: Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin Journal: J Mammary Gland Biol Neoplasia Date: 2014-06-22 Impact factor: 2.673
Authors: Ian K Komenaka; Jesse N Nodora; Lisa Madlensky; Lisa M Winton; Meredith A Heberer; Richard B Schwab; Jeffrey N Weitzel; Maria Elena Martinez Journal: J Community Genet Date: 2015-12-21
Authors: Melanie Ruszczyk; Gary Zirpoli; Shicha Kumar; Elisa V Bandera; Dana H Bovbjerg; Lina Jandorf; Thaer Khoury; Helena Hwang; Gregory Ciupak; Karen Pawlish; Pepper Schedin; Patricia Masso-Welch; Christine B Ambrosone; Chi-Chen Hong Journal: Cancer Causes Control Date: 2015-11-30 Impact factor: 2.506
Authors: Lu Chen; Christopher I Li; Mei-Tzu C Tang; Peggy Porter; Deirdre A Hill; Charles L Wiggins; Linda S Cook Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-15 Impact factor: 4.254
Authors: Christine B Ambrosone; Gary R Zirpoli; Dana Howard Bovbjerg; Jyoti Shankar; Chi-Chen Hong; Susan E McCann; Melanie Ruszczyk; Thaer Khoury; Song Yao; Gregory L Ciupak; Lina Jandorf; Karen S Pawlish; Elisa V Bandera Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-04-09 Impact factor: 4.254
Authors: Julie R Palmer; Emma Viscidi; Melissa A Troester; Chi-Chen Hong; Pepper Schedin; Traci N Bethea; Elisa V Bandera; Virginia Borges; Craig McKinnon; Christopher A Haiman; Kathryn Lunetta; Laurence N Kolonel; Lynn Rosenberg; Andrew F Olshan; Christine B Ambrosone Journal: J Natl Cancer Inst Date: 2014-09-15 Impact factor: 13.506
Authors: Hyuna Sung; Beena C R Devi; Tieng S Tang; Philip S Rosenberg; William F Anderson; Xiaohong R Yang Journal: Int J Cancer Date: 2019-12-23 Impact factor: 7.316